ReviewJournal of neuro-oncology2018

RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway.

Jikui Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.